SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-117308
Filing Date
2023-11-13
Accepted
2023-11-13 16:58:02
Documents
16
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330576d1_8k.htm   iXBRL 8-K 27865
2 EXHIBIT 99.1 tm2330576d1_ex99-1.htm EX-99.1 74955
6 GRAPHIC tm2330576d1_ex99-1img001.jpg GRAPHIC 15830
7 GRAPHIC tm2330576d1_ex99-1img002.jpg GRAPHIC 86610
8 GRAPHIC tm2330576d1_ex99-1img003.jpg GRAPHIC 44187
  Complete submission text file 0001104659-23-117308.txt   488388

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elox-20231113.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20231113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20231113_pre.xml EX-101.PRE 22365
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2330576d1_8k_htm.xml XML 3230
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 231399792
SIC: 2836 Biological Products, (No Diagnostic Substances)